89 related articles for article (PubMed ID: 28437084)
1. Affinity Binding of EMR2 Expressing Cells by Surface-Grafted Chondroitin Sulfate B.
Burzava ALS; Jasieniak M; Cockshell MP; Bonder CS; Harding FJ; Griesser HJ; Voelcker NH
Biomacromolecules; 2017 Jun; 18(6):1697-1704. PubMed ID: 28437084
[TBL] [Abstract][Full Text] [Related]
2. The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans.
Stacey M; Chang GW; Davies JQ; Kwakkenbos MJ; Sanderson RD; Hamann J; Gordon S; Lin HH
Blood; 2003 Oct; 102(8):2916-24. PubMed ID: 12829604
[TBL] [Abstract][Full Text] [Related]
3. Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells.
Kwakkenbos MJ; Pouwels W; Matmati M; Stacey M; Lin HH; Gordon S; van Lier RA; Hamann J
J Leukoc Biol; 2005 Jan; 77(1):112-9. PubMed ID: 15498814
[TBL] [Abstract][Full Text] [Related]
4. Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue.
Kop EN; Kwakkenbos MJ; Teske GJ; Kraan MC; Smeets TJ; Stacey M; Lin HH; Tak PP; Hamann J
Arthritis Rheum; 2005 Feb; 52(2):442-50. PubMed ID: 15693006
[TBL] [Abstract][Full Text] [Related]
5. Chondroitin sulfate coatings display low platelet but high endothelial cell adhesive properties favorable for vascular implants.
Thalla PK; Fadlallah H; Liberelle B; Lequoy P; De Crescenzo G; Merhi Y; Lerouge S
Biomacromolecules; 2014 Jul; 15(7):2512-20. PubMed ID: 24927450
[TBL] [Abstract][Full Text] [Related]
6. Facile surface functionalization with glycosaminoglycans by direct coating with mussel adhesive protein.
Choi BH; Choi YS; Hwang DS; Cha HJ
Tissue Eng Part C Methods; 2012 Jan; 18(1):71-9. PubMed ID: 21895565
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease.
Malavaki C; Mizumoto S; Karamanos N; Sugahara K
Connect Tissue Res; 2008; 49(3):133-9. PubMed ID: 18661328
[TBL] [Abstract][Full Text] [Related]
8. Modern developments in mass spectrometry of chondroitin and dermatan sulfate glycosaminoglycans.
Sisu E; Flangea C; Serb A; Zamfir AD
Amino Acids; 2011 Jul; 41(2):235-56. PubMed ID: 20632047
[TBL] [Abstract][Full Text] [Related]
9. Chondroitin sulfate/dermatan sulfate sulfatases from mammals and bacteria.
Wang S; Sugahara K; Li F
Glycoconj J; 2016 Dec; 33(6):841-851. PubMed ID: 27526113
[TBL] [Abstract][Full Text] [Related]
10. Molecular interactions between chondroitin-dermatan sulfate and growth factors/receptors/matrix proteins.
Mizumoto S; Yamada S; Sugahara K
Curr Opin Struct Biol; 2015 Oct; 34():35-42. PubMed ID: 26164146
[TBL] [Abstract][Full Text] [Related]
11. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects.
Pieper JS; Hafmans T; Veerkamp JH; van Kuppevelt TH
Biomaterials; 2000 Mar; 21(6):581-93. PubMed ID: 10701459
[TBL] [Abstract][Full Text] [Related]
12. Structural features and binding properties of chondroitin sulfates, dermatan sulfate, and heparan sulfate.
Casu B
Semin Thromb Hemost; 1991; 17 Suppl 1():9-14. PubMed ID: 1906198
[No Abstract] [Full Text] [Related]
13. Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-binding domain.
Lewandowska K; Choi HU; Rosenberg LC; Zardi L; Culp LA
J Cell Biol; 1987 Sep; 105(3):1443-54. PubMed ID: 2958485
[TBL] [Abstract][Full Text] [Related]
14. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of chondroitin/dermatan sulfate.
Silbert JE; Sugumaran G
IUBMB Life; 2002 Oct; 54(4):177-86. PubMed ID: 12512856
[TBL] [Abstract][Full Text] [Related]
16. Comparative domain modeling of human EGF-like module EMR2 and study of interaction of the fourth domain of EGF with chondroitin 4-sulphate.
Rani M; Dikhit MR; Sahoo GC; Das P
J Biomed Res; 2011 Mar; 25(2):100-10. PubMed ID: 23554678
[TBL] [Abstract][Full Text] [Related]
17. Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect.
Bougatef H; Krichen F; Capitani F; Amor IB; Maccari F; Mantovani V; Galeotti F; Volpi N; Bougatef A; Sila A
Carbohydr Polym; 2018 Sep; 196():272-278. PubMed ID: 29891297
[TBL] [Abstract][Full Text] [Related]
18. Colloidal force spectroscopy and cell biological investigations on biomimetic polyelectrolyte multilayer coatings composed of chondroitin sulfate and heparin.
Grohmann S; Rothe H; Frant M; Liefeith K
Biomacromolecules; 2011 Jun; 12(6):1987-97. PubMed ID: 21491904
[TBL] [Abstract][Full Text] [Related]
19. Degradation of chondroitin sulfate and dermatan sulfate with chondroitin lyases.
Hernáiz MJ; Linhardt RJ
Methods Mol Biol; 2001; 171():363-71. PubMed ID: 11450250
[No Abstract] [Full Text] [Related]
20. Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection.
Banfield BW; Leduc Y; Esford L; Visalli RJ; Brandt CR; Tufaro F
Virology; 1995 Apr; 208(2):531-9. PubMed ID: 7747425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
